long ago, record companies routinely paid radio stations large kickbacks to get
airplay for their featured artists.
may not be affecting the music industry as much anymore, but the
concept may have moved to the health-care industry, as evidenced by the recent
$28 million Omnicare settlement. Omnicare allegedly accepted kickbacks from
Abbott Labs in return for recommending the anti-epileptic drug Depakote to
nursing home patients. The kickbacks were allegedly disguised as grants and
educational funding, and the settlement said Abbott Labs also paid for Omnicare
meetings in Florida and gave company management tickets to sporting events.
Gejaa Gobena, an attorney with Hogan Lovells in Washington, told me that the settlement is notable because it indicates that the Department of Justice is not just focusing on drug companies that are paying kickbacks, but also on the companies that are receiving the kickbacks. “You combine that with the focus on individuals in light of the Yates memorandum, and it's clear that pharmaceutical fraud cases going forward aren't going to be just about the pharmaceutical company at the center of the investigation,” Gobena said.
Omnicare, which provides pharmacy services to nursing homes, was acquired by CVS Health Corp. in 2015 and operates as a wholly owned subsidiary, while Abbott Labs spun off its branded pharmaceuticals, including Depakote, into a new company called AbbVie. AbbVie was founded in January 2013.
I also spoke with Reuben Guttman, an attorney with Guttman, Buschner & Brooks PLLC in Washington, who told me the kickback scheme “exposes the backdoor dealing that results in patients, in this case the elderly, taking drugs not for medical necessity but for reasons of monetary gain.”
Guttman was the lead counsel for Meredith McCoyd, who filed a whistle-blower suit in 2007 alleging that Abbott Labs paid kickbacks to induce Omnicare pharmacists to prescribe Abbott drugs to nursing home residents. McCoyd received $3 million out of the $28 million settlement.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)